Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions

Kim et al completed a pooled analysis of 8 National Surgical Adjuvant Breast and Bowel Project trials and highlight that, when compared with White patients, Black patients with estrogen receptor–positive (ER+) breast cancer have worse distant recurrence‐free survival, especially in the setting of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Veronica C., Kruper, Laura, Mortimer, Joanne, Ashing, Kimlin T., Seewaldt, Victoria L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325488/
https://www.ncbi.nlm.nih.gov/pubmed/35578909
http://dx.doi.org/10.1002/cncr.34243
_version_ 1784757064341389312
author Jones, Veronica C.
Kruper, Laura
Mortimer, Joanne
Ashing, Kimlin T.
Seewaldt, Victoria L.
author_facet Jones, Veronica C.
Kruper, Laura
Mortimer, Joanne
Ashing, Kimlin T.
Seewaldt, Victoria L.
author_sort Jones, Veronica C.
collection PubMed
description Kim et al completed a pooled analysis of 8 National Surgical Adjuvant Breast and Bowel Project trials and highlight that, when compared with White patients, Black patients with estrogen receptor–positive (ER+) breast cancer have worse distant recurrence‐free survival, especially in the setting of neoadjuvant chemotherapy when pathologic complete response is not achieved. This editorial highlights that, to comprehend the drivers of this disparity, we must have more robust definitions of ER+ breast cancer and race.
format Online
Article
Text
id pubmed-9325488
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93254882022-07-30 Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions Jones, Veronica C. Kruper, Laura Mortimer, Joanne Ashing, Kimlin T. Seewaldt, Victoria L. Cancer Editorials Kim et al completed a pooled analysis of 8 National Surgical Adjuvant Breast and Bowel Project trials and highlight that, when compared with White patients, Black patients with estrogen receptor–positive (ER+) breast cancer have worse distant recurrence‐free survival, especially in the setting of neoadjuvant chemotherapy when pathologic complete response is not achieved. This editorial highlights that, to comprehend the drivers of this disparity, we must have more robust definitions of ER+ breast cancer and race. John Wiley and Sons Inc. 2022-05-17 2022-07-15 /pmc/articles/PMC9325488/ /pubmed/35578909 http://dx.doi.org/10.1002/cncr.34243 Text en © 2022 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Editorials
Jones, Veronica C.
Kruper, Laura
Mortimer, Joanne
Ashing, Kimlin T.
Seewaldt, Victoria L.
Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title_full Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title_fullStr Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title_full_unstemmed Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title_short Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions
title_sort understanding drivers of the black:white breast cancer mortality gap: a call for more robust definitions
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325488/
https://www.ncbi.nlm.nih.gov/pubmed/35578909
http://dx.doi.org/10.1002/cncr.34243
work_keys_str_mv AT jonesveronicac understandingdriversoftheblackwhitebreastcancermortalitygapacallformorerobustdefinitions
AT kruperlaura understandingdriversoftheblackwhitebreastcancermortalitygapacallformorerobustdefinitions
AT mortimerjoanne understandingdriversoftheblackwhitebreastcancermortalitygapacallformorerobustdefinitions
AT ashingkimlint understandingdriversoftheblackwhitebreastcancermortalitygapacallformorerobustdefinitions
AT seewaldtvictorial understandingdriversoftheblackwhitebreastcancermortalitygapacallformorerobustdefinitions

Ejemplares similares